LEADER 01347nam--2200409---450- 001 990003087470203316 005 20091112165811.0 010 $a978-0-19-920306-2 035 $a000308747 035 $aUSA01000308747 035 $a(ALEPH)000308747USA01 035 $a000308747 100 $a20080327d2007----km-y0itay50------ba 101 $aeng 102 $aUS 105 $a||||||||001yy 200 1 $aComplementary Protection in International Refugee Law$fJan McAdam 210 $aOxford [etc.]$cOxford University Press$d2007 215 $aXXXVII, 283 p.$d24 cm 225 2 $aOxford monographs in international law 410 0$12001$aOxford monographs in international law 606 0 $aRifugiati$xDiritto internazionale 606 0 $aRifugiati$xDiritti umani 606 0 $aAsilo 676 $a341.481 700 1$aMcADAM,$bJane$0507072 801 0$aIT$bsalbc$gISBD 912 $a990003087470203316 951 $aXXIII.1.H. 506 (IG VIII 16 ING 1222)$b58615 G.$cXXIII.1.H. 506 (IG VIII)$d00214422 959 $aBK 969 $aGIU 979 $aGIUSY$b90$c20080327$lUSA01$h1120 979 $aGIUSY$b90$c20080327$lUSA01$h1122 979 $aGIUSY$b90$c20080327$lUSA01$h1245 979 $aRSIAV5$b90$c20091112$lUSA01$h1658 996 $aComplementary protection in international refugee law$9777714 997 $aUNISA LEADER 05451nam 2200805Ia 450 001 9910813414803321 005 20200520144314.0 010 $a9786610197866 010 $a9781280197864 010 $a1280197862 010 $a9780470790311 010 $a0470790318 010 $a9781435616684 010 $a1435616685 010 $a9780470987360 010 $a0470987367 010 $a9781405140157 010 $a1405140151 035 $a(CKB)1000000000002764 035 $a(EBL)228559 035 $a(OCoLC)189594745 035 $a(SSID)ssj0000151299 035 $a(PQKBManifestationID)11151312 035 $a(PQKBTitleCode)TC0000151299 035 $a(PQKBWorkID)10282003 035 $a(PQKB)10359488 035 $a(MiAaPQ)EBC228559 035 $a(Au-PeEL)EBL228559 035 $a(CaPaEBR)ebr10240408 035 $a(CaONFJC)MIL19786 035 $a(OCoLC)936895069 035 $a(Perlego)2759796 035 $a(EXLCZ)991000000000002764 100 $a20030812d2003 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEvidence-based oncology /$fedited by Chris Williams ; associate editors, Vivien Bramwell ... [et al.] 205 $a1st ed. 210 $aLondon $cBMJ$d2003 215 $a1 online resource (636 p.) 225 1 $aEvidence-Based Medicine 300 $aDescription based upon print version of record. 311 08$a9780727914392 311 08$a0727914391 320 $aIncludes bibliographical references and index. 327 $aEvidence-based Oncology; Contents; Contributors; Preface; Abbreviations; Levels of evidence and grades of recommendation; Section I: Principles and practice of "critical appraisal"; 1 Appraising clinical literature in cancer; 2 Finding the "best evidence" for cancer care; 3 Understanding the concepts behind health economics; 4 Stringent application of epidemiological criteria changes the interpretation of the effects of immunotherapy in advanced renal cell cancer; Section II: Cancer prevention; Preface; 5 Which interventions help individuals to stop smoking?; 6 Breast cancer prevention trials 327 $a7 Is cancer risk reduced by a health-enhancing diet? 8 Is cancer risk reduced by the intake or supplementation of retinoids and carotenoids?; 9 Do primary and secondary prevention interventions for sun protection reduce the risk of skin cancers?; 10 Do sunscreens reduce the incidence of skin cancers?; 11 Can lifestyle behaviour change reduce the risk and incidence of urological cancers?; 12 What is the role of prophylactic surgery in the prevention of colorectal cancer?; Section III: Screening for cancers; 13 Screening for breast cancer; 14 Cervical screening; 15 Screening for prostate cancer 327 $a16 Screening for ovarian cancer 17 Screening for colorectal cancer; 18 Screening for lung cancer; 19 Screening for stomach cancer; 20 Screening for melanoma; Section IV: Treating tumours of the respiratory system; 21 Lung cancer; 22 Malignant pleural mesothelioma; Section V: Treating tumours of the gastrointestinal tract; 23 Cancer of the oesophagus; 24 Gastric carcinoma; 25 Pancreatic cancer; 26 Hepatobiliary cancers; 27 The treatment of cancers of the small bowel; 28 The treatment of carcinoma of the colon and rectum; 29 Treatment of anal cancer 327 $aSection VI: Treating tumours of the urogenital system 30 Kidney cancer; 31 Cancer of the bladder; 32 Cancer of the prostate; 33 Cancer of the penis; 34 Testicular germ cell cancer; Section VII: Treating gynaecological tumours; 35 Ovarian and fallopian tube cancers; 36 Cancer of the uterine corpus; 37 Cancer of the cervix and vagina; 38 Treating vulval cancer; 39 Gestational trophoblastic disease; Section VIII: Treating breast cancer; 40 Breast cancer; Section IX: Treating skin cancer; 41 Cutaneous melanoma; 42 Treatment of basal cell carcinoma; 43 Squamous cell carcinoma 327 $a44 Primary cutaneous T-cell lymphoma 45 Kaposi's sarcoma; Section X: Treating sarcomas; 46 Soft tissue sarcoma; Section XI: Treating central nervous system tumours; 47 Central nervous system tumours; Section XII: Treating cancers of the eye and associated structures; 48 Uveal melanoma; 49 Ocular adnexal and orbital tumours; Index 330 $aThis is a book about using the best evidence to inform treatment decisions for people with cancer. It is written by oncologists for oncologists, using examples throughout to illustrate key points. The book starts off with a ""toolbox"" section, written in a way which will help those relatively new to the principles of evidence-based oncology to understand the key issues, and equip them with the basics of how to tell a good study from a bad one. The majority of the book then deals with an evidence-based summary of the common and important cancers in a structured and easy to read format around 410 0$aEvidence-Based Medicine 606 $aOncology 606 $aCancer$xPatients$xMedical care 606 $aEvidence-based medicine 615 0$aOncology. 615 0$aCancer$xPatients$xMedical care. 615 0$aEvidence-based medicine. 676 $a616.994 701 $aWilliams$b C. J$g(Christopher John Hacon)$0892236 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910813414803321 996 $aEvidence-based oncology$91992414 997 $aUNINA